Apparently, pills can indeed be referred to as the next battleground for the drugmakers, who went on to establish the booming GLP-1 space that some analysts say could as well be worth around $100 billion by the end of the decade
Treating all patients with the same medication is increasingly seen as an oversimplification
Pharmacogenomics is the ability to modify how a drug works in relation to ones genetic code
Avoid ingestion, inhalation, and direct contact
Because of all this, GHK is being explored as a potential tool to help protect the brain, support healthy aging and possibly reduce age-related cognitive decline. Researchers are also investigating whether GHK-Cu could support nerve regeneration, lung healing and cellular repair pathways linked to inflammation
There are also ways to reduce the weight you might gain and to keep building muscle after stopping GLP-1